Assessment of eGFR 88 mL/min/1.73 m² and Urine Creatinine 166.1 mg/dL
An eGFR of 88 mL/min/1.73 m² represents normal kidney function and requires no kidney-specific interventions beyond annual monitoring and cardiovascular risk management. 1
Classification and Clinical Significance
This eGFR falls within the normal to mildly decreased range and does not meet criteria for chronic kidney disease (CKD), which is defined as eGFR <60 mL/min/1.73 m² or albuminuria ≥30 mg/g persisting for at least 3 months. 1
Normal GFR is approximately 130 mL/min/1.73 m² for men and 120 mL/min/1.73 m² for women, with an average decline of 0.75 mL/min/year beginning in the third to fourth decade of life. 2, 3
The threshold defining CKD is loss of half or more of normal kidney function (eGFR <60 mL/min/1.73 m²), which this patient has not reached. 1
Healthy adults have eGFR values >63.5 mL/min/1.73 m², and values in this range overlap with CKD stages 1 and 2, meaning an eGFR >60 mL/min/1.73 m² does not exclude kidney disease if other markers of damage are present. 4
Urine Creatinine Interpretation
The urine creatinine value of 166.1 mg/dL alone has limited clinical utility without knowing the corresponding urine albumin concentration to calculate the albumin-to-creatinine ratio (UACR). 2
Spot urine creatinine measurements are susceptible to false-negative and false-positive determinations due to variations in urine concentration related to hydration status. 2
You must obtain a simultaneous urine albumin measurement to calculate UACR, which is the standard screening test for kidney damage. 2
Required Screening and Monitoring
Check for albuminuria immediately using UACR to determine if kidney damage is present despite the normal eGFR. 1
Normal UACR is <30 mg/g creatinine; values of 30-299 mg/g indicate moderately increased albuminuria, and ≥300 mg/g indicates severely increased albuminuria. 2
Repeat eGFR and UACR annually to monitor for development of kidney disease, as recommended for patients with diabetes or hypertension. 2, 1
For patients with diabetes and duration ≥5 years (type 1) or all patients with type 2 diabetes, annual screening with both eGFR and UACR is mandatory. 2
Do not diagnose CKD based on a single eGFR measurement; CKD requires persistent abnormalities for ≥3 months. 1
Management Approach
Focus on cardiovascular risk reduction rather than kidney-specific interventions. 1
Target blood pressure <130/80 mmHg if hypertension or diabetes is present. 1
Optimize glucose control if diabetic to reduce future risk of kidney disease development. 2
Avoid nephrotoxic medications, particularly NSAIDs, which reduce renal blood flow and can precipitate acute kidney injury even with normal baseline kidney function. 1, 3
Medication Considerations
No medication dose adjustments are required at eGFR 88 mL/min/1.73 m², as renally excreted medications generally require adjustment only when eGFR falls below 60 mL/min/1.73 m². 1, 3
Standard dosing of common medications including thiazide diuretics, potassium citrate, and allopurinol can be used without modification. 3
When Nephrology Referral is NOT Indicated
Nephrology referral is not indicated for isolated eGFR of 88 mL/min/1.73 m² in the absence of albuminuria or other markers of kidney damage. 1
Referral becomes appropriate only if eGFR falls below 30 mL/min/1.73 m² or persistent albuminuria ≥300 mg/g develops. 1
Earlier referral at eGFR <45 mL/min/1.73 m² is recommended if other high-risk features are present, such as rapidly declining kidney function or uncertain etiology. 2
Screening for CKD Complications
- No screening for CKD complications (anemia, mineral bone disease, metabolic acidosis) is indicated at this eGFR level, as these complications occur when eGFR falls below 45-60 mL/min/1.73 m². 1
Critical Pitfalls to Avoid
Do not use serum creatinine alone to assess kidney function; always calculate eGFR using validated equations (CKD-EPI or MDRD). 1
Serum creatinine concentration is influenced by age, muscle mass, and hydration status, making it an inadequate standalone marker. 2
In elderly patients or those with extremes of muscle mass, creatinine-based eGFR may be inaccurate; consider cystatin C-based eGFR if clinical suspicion exists for discordant results. 5
Do not overlook the need for UACR measurement, as current strategies using serum creatinine alone miss 38-42% of patients with clinically meaningful kidney disease. 6
- Even patients with normal eGFR can have significant albuminuria indicating kidney damage and increased cardiovascular risk. 7